FDA approves nasal spray as first needle-free treatment for anaphylaxis

The FDA has approved a nasal spray as the first needle-free treatment for potentially fatal allergic reactions. The spray is intended as an alternative to EpiPen and other autoinjectors.  NBC News Health

​The FDA has approved a nasal spray as the first needle-free treatment for potentially fatal allergic reactions. The spray is intended as an alternative to EpiPen and other autoinjectors.